ITGA11 and neoplasm: However, the antitumor effects of siRNA in a mouse xenograft tumor model demonstrated that ITGA11 siRNA treatment outperformed EZH2 siRNA treatment, indicating the superior efficacy of ITGA11 siRNA in suppressing tumor growth.